ClinConnect ClinConnect Logo
Search / Trial NCT02487420

Gradual Egg-tolerance Induction in Hen's Egg Allergic Children

Launched by DOMINQUE BULLENS · Jun 29, 2015

Trial Information

Current as of May 30, 2025

Unknown status

Keywords

ClinConnect Summary

1. The investigators here want to test the hypothesis that a total period of 18 months of gradual open introduction of a certain egg product with regard to full egg tolerance induction is not inferior when compared to a total period of 30 months gradual open introduction of a certain egg product (see steps for the specific egg products) after tolerance to baked egg has been obtained.
2. The investigators also want to define step-specific 'tolerance-failures' and study the relevance of specific IgE to specific egg components to predict failures at each step.

Step 1: open baked egg test pass...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Children (1-18y) had or have a clinical diagnosis of IgE mediated hen's egg allergy based on positive history as well as skin prick testing and/or specific IgE detection by CAPtest in an allergy clinic
  • 2. Children are at least 12 months old before introduction of heated egg is considered
  • 3. Children did not suffer from a moderate-to-severe anaphylaxis due to egg-ingestion at presentation
  • 4. Children have specific IgE levels to Gal d 1 below 1.2 kU/mL or passed cake provocation test -
  • Exclusion Criteria:
  • 1. Children had a moderate-to severe anaphylaxis due to egg ingestion
  • 2. Children are younger than 12 months old at the moment of passing heated egg open provocation test
  • 3. Parents are not able or not willing to test a certain step in the tolerance induction at home -

About Dominque Bullens

Dominique Bullens is an esteemed clinical trial sponsor dedicated to advancing medical research through innovative study designs and robust trial management. With a focus on enhancing patient outcomes, the organization collaborates with a network of healthcare professionals and research institutions to conduct high-quality clinical trials across various therapeutic areas. Committed to ethical standards and regulatory compliance, Dominique Bullens leverages cutting-edge technology and data analytics to ensure the integrity and efficiency of its trials, ultimately contributing to the development of safe and effective medical interventions.

Locations

Leuven, Vlaams Brabant, Belgium

Hasselt, , Belgium

Bonheiden, , Belgium

Brugge, , Belgium

Ghent, , Belgium

Oostende, , Belgium

Patients applied

0 patients applied

Trial Officials

Dominique MA Bullens, MD, PhD

Principal Investigator

UZ Leuven

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials